Endoscopic submucosal dissection for recurrent or residual superficial esophageal cancer after chemoradiotherapy: Two cases

Changhyeok Hwang, Young Hoon Youn, Sung eun Choi, Young Hak Jung, Hae Yeul Park, Jae Jun Park, Jie Hyun Kim, Hyojin Park

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.

Original languageEnglish
Pages (from-to)553-557
Number of pages5
JournalClinical Endoscopy
Volume48
Issue number6
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Chemoradiotherapy
Esophageal Neoplasms
Digestive System Endoscopy
Esophageal Squamous Cell Carcinoma
Endoscopic Mucosal Resection
Recurrence
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Hwang, Changhyeok ; Youn, Young Hoon ; Choi, Sung eun ; Jung, Young Hak ; Park, Hae Yeul ; Park, Jae Jun ; Kim, Jie Hyun ; Park, Hyojin. / Endoscopic submucosal dissection for recurrent or residual superficial esophageal cancer after chemoradiotherapy : Two cases. In: Clinical Endoscopy. 2015 ; Vol. 48, No. 6. pp. 553-557.
@article{97787b8ee8ca44fab5e219849750438f,
title = "Endoscopic submucosal dissection for recurrent or residual superficial esophageal cancer after chemoradiotherapy: Two cases",
abstract = "We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.",
author = "Changhyeok Hwang and Youn, {Young Hoon} and Choi, {Sung eun} and Jung, {Young Hak} and Park, {Hae Yeul} and Park, {Jae Jun} and Kim, {Jie Hyun} and Hyojin Park",
year = "2015",
month = "1",
day = "1",
doi = "10.5946/ce.2015.48.6.553",
language = "English",
volume = "48",
pages = "553--557",
journal = "Clinical Endoscopy",
issn = "2234-2400",
publisher = "Korean Society of Gastrointestinal Endoscopy",
number = "6",

}

Endoscopic submucosal dissection for recurrent or residual superficial esophageal cancer after chemoradiotherapy : Two cases. / Hwang, Changhyeok; Youn, Young Hoon; Choi, Sung eun; Jung, Young Hak; Park, Hae Yeul; Park, Jae Jun; Kim, Jie Hyun; Park, Hyojin.

In: Clinical Endoscopy, Vol. 48, No. 6, 01.01.2015, p. 553-557.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endoscopic submucosal dissection for recurrent or residual superficial esophageal cancer after chemoradiotherapy

T2 - Two cases

AU - Hwang, Changhyeok

AU - Youn, Young Hoon

AU - Choi, Sung eun

AU - Jung, Young Hak

AU - Park, Hae Yeul

AU - Park, Jae Jun

AU - Kim, Jie Hyun

AU - Park, Hyojin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.

AB - We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84948699614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948699614&partnerID=8YFLogxK

U2 - 10.5946/ce.2015.48.6.553

DO - 10.5946/ce.2015.48.6.553

M3 - Article

AN - SCOPUS:84948699614

VL - 48

SP - 553

EP - 557

JO - Clinical Endoscopy

JF - Clinical Endoscopy

SN - 2234-2400

IS - 6

ER -